The recent discovery and characterization of Ark, the Drosophila homolog of the mammalian cell-death adaptor protein Apaf-1, have revealed that, like Apaf-1, this protein is important in multiple apoptosis pathways. The new findings also suggest that cell death in flies is very similar to that in mammals after all.
The molecular mechanisms of apoptosis are highly conserved throughout evolution. The homologs of genes essential for apoptosis in Caenorhabditis elegans have been shown to be important for apoptosis in mammalian systems: the C. elegans ced-3 gene encodes a protein homologous to the mammalian caspase family of apoptotic proteases [1] ; ced-4 to mammalian apaf-1, which encodes an adaptor protein that activates caspases [2] ; and ced-9 to the anti-apoptotic members of the bcl-2 family of mammalian cell-death regulators [3] . In the case of Drosophila, however, there has been speculation that the process of apoptosis had somehow been modified. Although the executioners of apoptosis, the caspases, were found to be conserved in flies, neither apaf-1 nor bcl-2 homologs had been reported. Three recent papers now report the identification of a fly ced-4/apaf-1 homolog [4] [5] [6] . These groups have named the gene dark, hac-1, and dapaf-1, respectively: in the on-line Drosophila database the gene is called ark, for apaf-1-related killer. Homologs of bcl-2 have also been identified in flies (P. Kurada and K.W., unpublished data, GenBank accession number AF216752; [5] ). These findings demonstrate that the mechanisms of apoptosis in flies are very likely to be the same as those that occur in worms and mammals.
Both C. elegans Ced-4 and mammalian Apaf-1 have already been shown to act as facilitators of caspase activation (reviewed in [7] ). In worms, Ced-4 forms a complex with Ced-3, enhancing Ced-3 activation. The anti-apoptotic protein Ced-9 binds to Ced-4 and inhibits the activation of Ced-3. Mammalian Apaf-1 seems to act in a similar manner, binding to caspase 9 and promoting its autoactivation. Anti-apoptotic members of the Bcl-2 family inhibit this activity, although they may not bind directly to Apaf-1. The recent Drosophila work shows that Ark also binds to caspases, specifically to the recently identified Dredd and Dronc proteases [4, 6] . Overexpression of a truncated form of Ark was able to induce apoptosis, and this apoptosis was inhibited by co-expression of a catalytically inactive form of Dredd [4] . This finding suggests that Ark binds to and activates Dredd, and that this activation is important for Ark's pro-apoptotic activity. The catalytically inactive Dredd may bind to Ark but would be unable to undergo auto-activation. Understanding how the Drosophila Bcl-2 homologs affect Ark function awaits their full characterization.
One interesting difference between Apaf-1 and Ced-4 is the presence of a WD-repeat domain in the mammalian protein. This domain acts as an inhibitor of Apaf-1 function. Apaf-1 is also regulated by cytochrome c, which is released from mitochondria into the cytosol as cells undergo apoptosis. Cytochrome c binds to the WD-repeat domains of Apaf-1 thereby relieving the negative regulation [8] . Deletion of the WD-repeat domain results in the generation of a constitutively active form of Apaf-1. In a similar manner, truncation of Ark by removal of its WD repeats also resulted in a potent apoptosis-inducing protein. Thus, Apaf-1 and Ark have acquired a level of regulation not seen with Ced-4. One of the groups working on Ark has also observed the presence of two forms of Ark, one that contains WD repeats and one that does not [6] . This group has found that mouse Apaf-1 may also be present in a form that lacks WD repeats. If this latter observation is confirmed, it suggests that both Ark and Apaf-1 function in cytochrome-c-dependent and cytochrome-c-independent manners. The two forms of Ark show differences in caspase binding specificity, and in the types of caspase activity they induce when overexpressed. Thus, the particular form of Ark that is expressed may serve to modulate the apoptosis response.
One model that has been proposed for the role of the Apaf-1-caspase-9 complex in apoptosis is that this complex acts as part of an amplification cycle. This model is based on the observation that, in the absence of Apaf-1, some cells are resistant to a variety of pro-apoptotic signals whereas other cells retain their sensitivity to these same signals [9] . In the cells that do not require Apaf-1 in order to undergo death, the apoptosis induction pathway is sufficient to activate caspases to a level that kills the cell, whereas in the resistant cells induction may lead only to sublethal caspase activity. Amplification of the caspase signal can be initiated by cytochrome c release from mitochondria, and subsequent derepression of Apaf-1. A recent study of mice deficient in the pro-apoptotic BH3 protein Bid suggests that Bid may be responsible for turning on this amplification cycle in response to activation of the Fas pathway [10] . In Bid-deficient liver cells, some caspase activation can be seen in response to Fas triggering. The caspase activation is only seen near the plasma membrane, however, and does not kill cells efficiently.
The data on Ark in flies supports the role of this protein in such an amplification cycle. Localization of cytochrome c was altered in response to both developmental inducers of apoptosis, and to staurosporine and cycloheximide. In Drosophila embryo extracts, cytochrome c was deduced to be sufficient to induce caspase activity [6] . The work was then taken a step further by showing that the WD-repeat domains of Ark bound to cytochrome c [4, 6] and, importantly, that caspase activation by cytochrome c was inhibited in the absence of Ark [6] . Thus, the induction of apoptosis can lead to Ark-dependent caspase activation in response to altered cytochrome c localization. Apoptosis could still occur in embryos lacking detectable Ark, however, albeit at a greatly reduced level [4] [5] [6] . Thus, some developmental apoptosis in flies may occur in the absence of Ark-mediated amplification, while in other cases the inductive signal is insufficient to induce apoptosis in the absence of Ark.
Apoptosis in Drosophila is regulated by three genes, head involution defective (hid), reaper (rpr) and grim (reviewed in [11] ). In the absence of all three genes, apoptosis in the developing embryo is completely blocked. These genes are thought to induce apoptosis by binding to and inactivating the inhibitor of apoptosis proteins or IAPs (reviewed in [12] ). IAPs prevent apoptosis by binding to caspases and inhibiting their activity. To understand the role that Ark plays in death induced by hid, rpr and grim, genetic interactions were studied in transgenic flies in which these genes were overexpressed in the eye, resulting in ectopic apoptosis. Allelic differences resulted in variability in the results reported but, on balance, the data suggest that death induced by all three of these cell-death regulators is reduced in the absence of Ark [4] . This finding supports the idea that Ark is a component of an amplification cycle that is required for apoptosis in some cells in response to several different inducers. The Ark amplification cycle may represent an integration point for regulatory inputs. In fact, the expression of Ark is high in a subset of cells doomed to die during development and is also increased following exposure of cells to ionizing radiation [5] . Thus, Ark expression may serve to sensitize cells to other death signals (Figure 1) .
One of the strengths of the Drosophila system is the ability to study the role of cell-death genes in the context of normal development. It is interesting to note that flies that lack detectable Ark are viable. In fact, it is still not known whether apoptosis is essential for viability in Drosophila. Flies deficient for Ark did show a variety of phenotypes, however, some of which resembled those resulting from mutations in other cell-death genes. The Ark mutants had a gnarled or blistered wing phenotype resembling that seen in flies lacking Hid, while the presence of extra bristles on Ark mutants is similar to the phenotype seen in Dredd mutants [4] . Inhibition of caspases during development also results in a similar bristle phenotype [6] . Importantly, the enlarged central nervous system reported in Ark mutants is like that seen in mice lacking Apaf-1 [9] . One surprising finding is the presence of extra photoreceptors in the eyes of Ark mutants. As the specification of the correct number of photoreceptors is not thought to involve apoptosis, this finding suggests that Ark has roles in other developmental pathways. This is clearly an intriguing area for further study. In addition, insights into the subcellular localization of Ark and its potential interaction with the Bcl-2 homologs may provide new ideas about the role of these proteins in developmentally regulated apoptosis.
In sum, the discovery of a fly Apaf-1 homolog demonstrates that cell death in flies does, after all, have many features in common with apoptosis in other organisms. It is likely, given the progress of the fly and human genome projects, that this conformation of common mechanisms will flow both ways. It is clear that there are sophisticated developmental controls of apoptosis in the fly that have not been found in mammalian systems -specifically the rpr, grim and hid genes. Of course, it is possible that these genes are fly 'inventions', but it seems more likely that the mammalian homologs are yet to be identified. In either case, investigation of the developmental regulation of apoptosis in the fly will certainly provide us with a better understanding of the role and regulation of this process in mammalian development and disease. 
